Decnupaz (pivekimab sunirine-pvzy) Coverage for BPDCN
Customize your policy alerts
Sign up for Empire Bluecross Policy CC-0304 alerts
Get alerted when Policy CC-0304 changes without checking for updates manually.
Monitor payer policy activity
This policy governs prior authorization and medical-necessity review for Decnupaz (pivekimab sunirine-pvzy), with coverage available for individuals under 19 years of age or for treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN).
New clinical criteria were established for Decnupaz coverage.
HCPCS codes C9399 and J9999 and ICD-10-CM code C86.40 were added for Decnupaz coding.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.